Andrew Steinsapir

Company: Apertura Gene Therapy

Job title: Acting Chief Technology Officer

Seminars:

Panel Discussion: Setting the Stage: Understanding the Evolving Landscape of Viral Vector Process Development 9:00 am

Delving into an overview of industry growth and the latest advancements shaping process development Addressing the hurdles in balancing quality, cost-efficiency, and regulatory demands as companies move from lab to commercial-scale production Exploring emerging technologies, including automation, PAT, and AI-driven analytics, that are redefining the future of viral vector productionRead more

day: Conference Day One